Showing 2111-2120 of 2314 results for "".
- CMS Relaxes Rules to Boost Capacity of Providers as Facilities Tackle COVID-19 Outbreakhttps://modernod.com/news/cms-relaxes-rules-to-boost-capacity-of-providers-as-facilities-tackle-covid-19-outbreak/2477562/The Trump administration has relaxed rules to enable doctors to remotely care for patients across state lines at rural facilities and let nurse practitioners perform more duties as workforce capacity becomes a major concern, according to a FierceHealthcare
- AAOpt and ASCO Establish Virtual Clinical Training Program to Keep Optometry Students on Graduation Trackhttps://modernod.com/news/aaopt-and-asco-establish-virtual-clinical-training-program-to-keep-optometry-students-on-graduation-track/2477542/With COVID-19 leaving students unable to see patients in person, the American Academy of Optometry (AAO) is establishing an unprecedented virtual clinical training program to help the nation’s 1,800 4th year prospective Doctors of Optometry accumulate the 350 clinical observation hours they need
- Retina Specialists in US Hot Zones Report on How Offices, ORs Have Changed During COVID-19 Spreadhttps://modernod.com/news/retina-specialists-in-us-hot-zones-report-on-how-offices-ors-have-changed-during-covid-19-spread/2477521/New Retina Radio, Retina Today’s podcast, featured a conversation with three doctors from hotspots in the United States. John W. Kitchens, MD, moderated a conversation with George Williams, MD, from the Oakland University School of Medicine, outside of Detroit; Gwen Cousins, MD, from Ret
- FDA Approves Anti-Malarial Drugs Chloroquine And Hydroxychloroquine For Emergency Coronavirus Treatmenthttps://modernod.com/news/fda-approves-anti-malarial-drugs-chloroquine-and-hydroxychloroquine-for-emergency-coronavirus-treatment/2477496/The Food and Drug Administration on Sunday issued an emergency authorization for experimental coronavirus treatments using chloroquine and hydroxychloroquine, anti-malaria drugs touted by President Donald Trump despite inconclusive clinical proof of their effectiveness, according to a Forbes
- OOTG Webcast: Weathering the Storm and Supporting Staffhttps://modernod.com/news/ootg-webcast-weathering-the-storm-and-supporting-staff/2477488/“Ophthalmology off the Grid” cohosts Gary Wörtz, MD, and Blake Williamson, MD, MPH, sat down—virtually—with Robert Weinstock, MD, and Elizabeth Yeu, MD, on March 27 to discuss how the COVID-19 crisis is
- Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19https://modernod.com/news/johnson-johnson-announces-a-lead-vaccine-candidate-for-covid-19/2477489/Johnson & Johnson announced a $1 billion deal with the U.S. government to create enough manufacturing capacity to make more than 1 billion doses of a potential vaccine for COVID-19. Johnson & Johnson said on Monday it has been working on a vaccine since January 2020 and expects to initiat
- Live Webcast: COVID-19 Impact on Retina Practiceshttps://modernod.com/news/live-webcast-covid-19-impact-on-retina-practices/2477468/Bryn Mawr Communications (BMC) will host a live video webcast of its New Retina Radio podcast on Friday at 12 pm ET. The webcast, “How Retina Doctors Are Altering Their Treatments During the COVID-19 Crisis, and How They Can Anticipate What’s Next,” will be hosted by John W. Kitchens, MD. Panelis
- Many Drugs Already Approved by FDA May Have Promise Against COVID-19https://modernod.com/news/many-drugs-already-approved-by-fda-may-have-promise-against-covid-19/2477451/Two new studies each suggest that dozens of drugs already approved for use in the United States may prove effective against the new coronavirus, according to
- ImprimisRx to Provide Healthcare Professionals With Telemedicine Serviceshttps://modernod.com/news/imprimisrx-to-provide-healthcare-professionals-with-telemedicine-services/2477446/ImprimisRx, a wholly-owned subsidiary of Harrow Health, announced that they have entered into an exclusive agreement with Doxy.me, a full-service telemedicine solution. The agreement will provide all ImprimisRx ophthalmology, optometry, and wellness practices with the Clinic level
- FDA Approves Genentech’s Clinical Trial for Actemra to Treat Hospitalized Patients With Severe COVID-19 Pneumoniahttps://modernod.com/news/fda-approves-genentechs-clinical-trial-for-actemra-to-treat-hospitalized-patients-with-severe-covid-19-pneumonia/2477442/Genentech announced Monday that the FDA has approved a randomized, double-blind, placebo-controlled phase 3 clinical trial in collaboration with the Biomedical Advanced Research and Development Authority (BARDA) to evaluate the safety and efficacy of intravenous Actemra (tocilizumab) plus standar